JP2008115162A - Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition - Google Patents
Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition Download PDFInfo
- Publication number
- JP2008115162A JP2008115162A JP2007237481A JP2007237481A JP2008115162A JP 2008115162 A JP2008115162 A JP 2008115162A JP 2007237481 A JP2007237481 A JP 2007237481A JP 2007237481 A JP2007237481 A JP 2007237481A JP 2008115162 A JP2008115162 A JP 2008115162A
- Authority
- JP
- Japan
- Prior art keywords
- liquid crystal
- skin
- emulsion composition
- emulsifier
- crystal forming
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 84
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 239000002537 cosmetic Substances 0.000 title claims abstract description 37
- 239000003995 emulsifying agent Substances 0.000 title claims abstract description 24
- 239000000839 emulsion Substances 0.000 title claims description 35
- 230000015572 biosynthetic process Effects 0.000 title claims description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 28
- 229930182558 Sterol Natural products 0.000 claims abstract description 20
- 150000003432 sterols Chemical class 0.000 claims abstract description 20
- 235000003702 sterols Nutrition 0.000 claims abstract description 20
- -1 polyoxyethylene Polymers 0.000 claims abstract description 18
- 239000000787 lecithin Substances 0.000 claims abstract description 7
- 235000010445 lecithin Nutrition 0.000 claims abstract description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 5
- 229940067606 lecithin Drugs 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 abstract description 17
- 150000002632 lipids Chemical class 0.000 abstract description 6
- 239000013078 crystal Substances 0.000 abstract description 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000008016 vaporization Effects 0.000 abstract 1
- 238000009834 vaporization Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 34
- 239000000047 product Substances 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 239000008213 purified water Substances 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 10
- 239000002994 raw material Substances 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 5
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 229940106189 ceramide Drugs 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 229940010747 sodium hyaluronate Drugs 0.000 description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 4
- 230000005068 transpiration Effects 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 235000002378 plant sterols Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 102000016679 alpha-Glucosidases Human genes 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229940033331 soy sterol Drugs 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- AMUTYVGRCVFCCD-UHFFFAOYSA-N 5,6-diaminopyridine-3-carboxylic acid Chemical compound NC1=CC(C(O)=O)=CN=C1N AMUTYVGRCVFCCD-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000144217 Limnanthes alba Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- CCDWGDHTPAJHOA-UHFFFAOYSA-N benzylsilicon Chemical compound [Si]CC1=CC=CC=C1 CCDWGDHTPAJHOA-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229940075510 carbopol 981 Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 125000001549 ceramide group Chemical group 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- UCTLRSWJYQTBFZ-DDPQNLDTSA-N cholesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC=C21 UCTLRSWJYQTBFZ-DDPQNLDTSA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- JWZSXZWCWMCYPE-RSAXXLAASA-M sodium;(4s)-4-amino-5-dodecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O JWZSXZWCWMCYPE-RSAXXLAASA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- DFIWJEVKLWMZBI-UHFFFAOYSA-M sodium;dihydrogen phosphate;phosphoric acid Chemical compound [Na+].OP(O)(O)=O.OP(O)([O-])=O DFIWJEVKLWMZBI-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、液晶形成用乳化剤およびそれを含有する液晶形成乳化組成物並びに化粧料に関し、さらには、安定でスキンケア効果に優れた化粧料に関する。 The present invention relates to an emulsifier for forming a liquid crystal, a liquid crystal forming emulsion composition containing the same, and a cosmetic, and further relates to a cosmetic that is stable and excellent in skin care effect.
肌を過乾燥などの過酷な外部環境から保護し、かつ、荒れ肌や乾燥肌などを予防あるいは改善し、さらには、加齢による皮膚の老化を防止する目的で、各種の油性原料を界面活性剤により乳化し、加えてグルセリン、ヒアルロン酸あるいはアミノ酸などの保湿剤や、ビタミンEなどの皮膚栄養剤を配合した化粧料が広く使用されてきた。 In order to protect the skin from harsh external environments such as overdrying, to prevent or improve rough skin, dry skin, etc., and to prevent aging of the skin due to aging, various oily raw materials are surfactants Cosmetics that have been emulsified and added with humectants such as glycerin, hyaluronic acid or amino acids, and skin nutrients such as vitamin E have been widely used.
これらの化粧料は、油および水を含む乳化層が皮膚上に塗布されることで、外部の刺激から皮膚を保護し、皮膚内部からの水分の蒸散を防ぐとともに、肌に一定量の水分を与えることで、荒れ肌や乾燥肌の改善に寄与している。 These cosmetics are coated with an emulsified layer containing oil and water on the skin to protect the skin from external irritation, prevent transpiration of moisture from the inside of the skin, and provide a certain amount of moisture to the skin. By giving, it contributes to the improvement of rough skin and dry skin.
ただし、これら従来技術による化粧料は、以下の点で不十分である。
(1)従来の化粧料は、主に、油が界面活性剤により乳化ミセルを形成し、連続相である水相に分散した水中油型(以下O/W型)構造であるので、これらを皮膚に塗布した場合、連続相である水は、短時間で蒸発飛散してしまい、十分な保湿効果を肌に及ぼすことができない。
(2)水分の蒸発飛散にともない乳化物が破壊されるため、含有する保湿剤や皮膚栄養剤を十分に皮膚内部へ浸透させることができず、望むべき効果を発揮させることができない。
(3)O/W型の従来の化粧料に使用される乳化剤は、親水性が高く、得られる乳化物は、水に溶解しやすい(耐水性が悪い)。したがって、これら高親水性の乳化剤で調製された化粧料を皮膚に塗布した場合、汗などで流れやすく、効果の持続性に乏しい。
(4)一方、化粧料には、連続相である油相に水が分散した油中水型(以下W/O型)構造も見られるが、これは、肌に塗布した感触がオイリーであり、使用感に問題がある。
However, these conventional cosmetics are insufficient in the following points.
(1) Conventional cosmetics mainly have an oil-in-water structure (hereinafter referred to as O / W type) in which oil forms emulsified micelles with a surfactant and is dispersed in a continuous aqueous phase. When applied to the skin, the water that is the continuous phase evaporates and scatters in a short time, and cannot provide a sufficient moisturizing effect to the skin.
(2) Since the emulsion is destroyed due to the evaporation and scattering of moisture, the contained humectant and skin nutrient cannot be sufficiently penetrated into the skin, and the desired effect cannot be exhibited.
(3) The emulsifier used in conventional O / W type cosmetics has high hydrophilicity, and the resulting emulsion is easily dissolved in water (poor water resistance). Therefore, when a cosmetic prepared with these highly hydrophilic emulsifiers is applied to the skin, it tends to flow with sweat or the like, and the effect persistence is poor.
(4) On the other hand, cosmetics also have a water-in-oil type (hereinafter referred to as W / O type) structure in which water is dispersed in an oil phase that is a continuous phase, but this is oily when applied to the skin. There is a problem with the usability.
近年これらの問題を解決する目的で、皮膚に対して親和性が大きく保湿効果や荒れ肌改善効果に優れた、角質細胞間脂質と類似の液晶構造をもつ液晶型の化粧料が提案されている。具体的には、天然あるいは合成のセラミドに高級脂肪酸、高級アルコール、糖脂質、コレステロールなどの両親媒性物質を組み合わせて、角質細胞間脂質に近い液晶構造を形成させる技術が開示されている(特許文献1参照)。 In recent years, for the purpose of solving these problems, liquid crystal type cosmetics having a liquid crystal structure similar to keratinocyte lipids, which have a high affinity for skin and excellent moisturizing effect and rough skin improving effect have been proposed. Specifically, there is disclosed a technique for forming a liquid crystal structure close to keratinocyte lipids by combining natural or synthetic ceramides with amphiphilic substances such as higher fatty acids, higher alcohols, glycolipids, and cholesterols (patents). Reference 1).
この技術は、セラミドが層状の液晶構造(ラメラ液晶構造)を形成し、内部に水分を結合水として保持することで、角質細胞の接着や水分保持に寄与する特性を利用している(非特許文献1、2参照)。 In this technology, ceramide forms a layered liquid crystal structure (lamellar liquid crystal structure) and retains moisture as bound water, thereby utilizing the properties that contribute to the adhesion and moisture retention of keratinocytes (non-patent) References 1 and 2).
ただし、この技術には、以下に示す問題点があり、満足すべき結果が得られていない。
(1)セラミドは、天然品および合成品も含めて結晶化しやすく、かつ、一般に化粧料に使用されている油性原料や溶剤に溶けにくい。したがって、製剤化が困難であり、しかも、経時的に製剤中で結晶化し、品質を損なうなどの問題を生じる。
(2)セラミド自体には乳化力がなく、また、乳化物中で結晶として析出することが懸念され、これを解決するために、種々の親水性界面活性剤を使用する必要があり、それらの皮膚刺激性が懸念される。
(3)さらに、非常に高価である。
However, this technique has the following problems, and satisfactory results have not been obtained.
(1) Ceramide is easily crystallized including natural products and synthetic products, and is hardly soluble in oily raw materials and solvents generally used in cosmetics. Therefore, it is difficult to formulate, and further, there arises problems such as crystallization in the formulation over time and loss of quality.
(2) Ceramide itself has no emulsifying power, and it is feared that it precipitates as crystals in the emulsion. In order to solve this, it is necessary to use various hydrophilic surfactants. There is concern about skin irritation.
(3) Furthermore, it is very expensive.
その他に液晶組成物を化粧料に配合する特許として、親水性界面活性剤、ステロールおよびα−グリセリルアルキルエーテルが形成する発色性液晶組成物の技術が開示されている(特許文献2〜5参照)。しかしこれらは、発色することが特長であり、スキンケア効果については疑問である。 In addition, as a patent for blending a liquid crystal composition into a cosmetic, a technology of a color forming liquid crystal composition formed by a hydrophilic surfactant, a sterol and an α-glyceryl alkyl ether is disclosed (see Patent Documents 2 to 5). . However, they are characterized by color development, and the skin care effect is questionable.
また、一般に液晶構造を利用してスキンケア効果を高める技術においては、製剤が皮膚に塗布・適用されている間、その液晶構造を安定に保持していることが必要である。皮膚上で液晶構造が消失すると、結晶水による継続的な保湿効果の発現などの液晶化粧料に期待される機能が失われる。 In general, in a technique for enhancing the skin care effect using a liquid crystal structure, it is necessary to stably hold the liquid crystal structure while the preparation is applied to and applied to the skin. When the liquid crystal structure disappears on the skin, the functions expected of the liquid crystal cosmetics such as the continuous moisturizing effect by crystal water are lost.
従来の技術は、皮膚に塗布すると、皮膚の温度や適用している間の水分蒸散などで液晶構造が消失する。適用中に皮膚上で液晶構造を安定に保つ技術は見出されていない。したがって、セラミドなどの高価でかつ製剤化のしにくい成分を使用することなく、肌を過乾燥などの過酷な外部環境から保護し、かつ、荒れ肌や乾燥肌などを予防あるいは改善しうる化粧料(皮膚状態改善型の化粧料)が望まれている。
本発明は角質細胞間脂質に類似の液晶構造を形成し、皮膚に塗布されている間も液晶構造を安定に保持し、高いスキンケア効果を発揮するとともに製剤化が容易な、新規液晶形成用乳化剤、それを含有する液晶形成乳化組成物および化粧料を提供することを目的とする。 The present invention provides a novel liquid crystal forming emulsifier that forms a liquid crystal structure similar to keratinocyte lipids, stably maintains the liquid crystal structure even when applied to the skin, exhibits a high skin care effect, and is easily formulated. An object of the present invention is to provide a liquid crystal-forming emulsion composition and a cosmetic containing the same.
本課題に対し、新規な化粧料を見出すために鋭意研究を行った結果、ステロール、ポリオキシエチレンステロール類およびレシチンを必須成分として含有する乳化剤を含有した組成物および化粧料は、角質細胞間脂質と類似の液晶構造を形成し、上記課題を解決できることを見出した。 As a result of diligent research to find a new cosmetic for this problem, a composition containing an emulsifier containing sterol, polyoxyethylene sterols, and lecithin as essential components, and the cosmetic, It was found that the above-mentioned problems can be solved by forming a similar liquid crystal structure.
本発明の液晶形成用乳化剤を含有する液晶形成乳化組成物または化粧料を皮膚に塗布した時に水分の蒸散を液晶が抑えることにより優れたスキンケア効果や皮膚状態改善効果を示した。 When the liquid crystal forming emulsion composition or cosmetic containing the liquid crystal forming emulsifier of the present invention was applied to the skin, the liquid crystal suppressed the transpiration of water, and thus showed excellent skin care effect and skin condition improving effect.
本発明に使用される(A)成分のステロールは、コレステロール、コレスタノール、ラノステロール、デヒドロコレステロールなどの動物性ステロール、βシトステロール、スチグマステロール、カンペステロール、エルゴステロールなどの植物性ステロール、ミコステロール、チモステロールなどの微生物由来のステロール類などが挙げられる。これらは、そのままでも、安定化のために水素添加などの化学処理を施されていてもよい。また、これらの1種または2種以上を組み合わせて使用することができる。これらの中で特に好ましいのは、コレステロール、コレスタノール、植物ステロール、植物スタノールである。 The sterol of the component (A) used in the present invention includes animal sterols such as cholesterol, cholestanol, lanosterol and dehydrocholesterol, plant sterols such as β-sitosterol, stigmasterol, campesterol and ergosterol, mycostol, Examples include sterols derived from microorganisms such as timosterol. These may be used as they are or may be subjected to chemical treatment such as hydrogenation for stabilization. Moreover, these 1 type (s) or 2 or more types can be used in combination. Among these, cholesterol, cholestanol, plant sterol, and plant stanol are particularly preferable.
本発明に使用される(B)成分としては、上記のステロールにエチレンオキサイドを付加し、ポリオキシエチレンステロールエーテルとしたもので、具体的には、植物性ステロールおよびその水素添加物(植物性スタノール)、動物性コレステロールおよびその水素添加物(動物性スタノール)などが挙げられる。ステロール類に対するエチレンオキサイドの付加モル数は、n=3〜100、好ましくはn=5〜50、さらに好ましくはn=10〜30である。 As the component (B) used in the present invention, ethylene oxide is added to the above sterol to form polyoxyethylene sterol ether. Specifically, plant sterol and its hydrogenated product (plant stanol) ), Animal cholesterol and its hydrogenated product (animal stanol), and the like. The number of moles of ethylene oxide added to sterols is n = 3 to 100, preferably n = 5 to 50, and more preferably n = 10 to 30.
本発明に使用される(C)成分としては、大豆レシチン、卵黄レシチン、水素添加大豆レシチン、水素添加卵黄レシチンなどのレシチン類、これらのレシチン類を酵素処理によりモノアシル体としたリゾレシチンおよびまたは水素添加リゾレシチン、ヒドロキシル化したヒドロキシレシチンなどを挙げることができる。また、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルイノシトール、ホスファチジン酸、ホスファチジルセリンなどのレシチン中のリン脂質分画物もそれぞれ単品およびまたは混合して使用できる。 As the component (C) used in the present invention, lecithins such as soybean lecithin, egg yolk lecithin, hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, lysolecithin and / or hydrogenated by converting these lecithins into monoacyl bodies by enzymatic treatment Examples include lysolecithin and hydroxylated hydroxylecithin. In addition, phospholipid fractions in lecithin such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, phosphatidic acid, and phosphatidylserine can be used individually or in combination.
本発明において、(A)〜(C)成分の比率(質量比)は、(A)/(B)=10/90〜90/10が好ましく、より好ましくは、(A)/(B)=20/80〜80/20、さらに好ましくは、(A)/(B)=20/80〜40/60である。 In the present invention, the ratio (mass ratio) of the components (A) to (C) is preferably (A) / (B) = 10/90 to 90/10, more preferably (A) / (B) = 20/80 to 80/20, and more preferably (A) / (B) = 20/80 to 40/60.
また、(A)成分と(B)成分の合計と(C)成分の比率(質量比)は、[(A)+(B)]/(C)=98/2〜70/30が好ましく、より好ましくは、[(A)+(B)]/(C)=95/5〜70/30、さらに好ましくは、[(A)+(B)]/(C)=90/10〜75/25である。この範囲において、液晶形成乳化組成物および化粧料がより安定に調製できる。 Further, the ratio (mass ratio) of the sum of the components (A) and (B) and the component (C) is preferably [(A) + (B)] / (C) = 98/2 to 70/30, More preferably, [(A) + (B)] / (C) = 95/5 to 70/30, and even more preferably, [(A) + (B)] / (C) = 90/10 to 75 / 25. Within this range, the liquid crystal-forming emulsion composition and the cosmetic can be prepared more stably.
本発明の液晶形成乳化剤は、(A)〜(C)成分のみで構成されても良く、あるいは油性原料を併用することもできる。(A)〜(C)成分の含有量は液晶形成乳化組成物全量または化粧料全量に対し、0.1〜30質量%を含有することが好ましい。より好ましくは、0.3〜20質量%、さらに好ましくは、0.5〜10質量%である。この範囲であれば液晶形成用乳化剤/スクワラン/水の系において、好ましいラメラ液晶やヘキサゴナル液晶が形成される。 The liquid crystal forming emulsifier of the present invention may be composed only of the components (A) to (C), or an oily raw material may be used in combination. It is preferable that content of (A)-(C) component contains 0.1-30 mass% with respect to liquid crystal forming emulsion composition whole quantity or cosmetics whole quantity. More preferably, it is 0.3-20 mass%, More preferably, it is 0.5-10 mass%. Within this range, preferred lamellar liquid crystals and hexagonal liquid crystals are formed in the liquid crystal forming emulsifier / squalane / water system.
本発明の液晶形成用乳化剤が(A)〜(C)成分と油性原料とを併用する場合、両者の好ましい混合比率(質量比)は、油性原料/[(A)〜(C)成分の合計量]=10/0.1〜0.1/10、より好ましくは、10/0.5〜0.5/10、さらに好ましくは、10/1〜1/10である。 When the emulsifier for liquid crystal formation of the present invention uses the components (A) to (C) and the oily raw material in combination, the preferred mixing ratio (mass ratio) of both is the sum of oily raw materials / [(A) to (C) components. Amount] = 10 / 0.1 to 0.1 / 10, more preferably 10 / 0.5 to 0.5 / 10, still more preferably 10/1 to 1/10.
油性原料は、一般に化粧品に使用される油性原料なら何れも好適に使用できる。具体的には、スクワラン、流動パラフィンなどの炭化水素類、オリーブ油、マカデミアンナッツ油、ホホバ油などの植物油、牛脂などの動物油、トリイソオクタン酸グリセリル、ミリスチン酸イソプロピル、イソオクタン酸セチル、パルミチン酸イソオクチルなどのエステル類、ジメチルシリコーン、フェニルメチルシリコーン、シクロメチコンなどのシリコーン類などが挙げられる。 As the oily raw material, any oily raw material generally used in cosmetics can be suitably used. Specifically, hydrocarbons such as squalane and liquid paraffin, vegetable oils such as olive oil, macadamian nut oil, jojoba oil, animal oils such as beef tallow, glyceryl triisooctanoate, isopropyl myristate, cetyl isooctanoate, isooctyl palmitate, etc. And esters such as dimethylsilicone, phenylmethylsilicone, and cyclomethicone.
本発明の液晶形成用乳化剤を含有する液晶形成乳化組成物および化粧料における液晶構造の有無は、液晶組成物を偏光顕微鏡で観察することで確認することができる。液晶組成物は、偏光顕微鏡での観察で、ラメラ液晶に独特の形状であるマルターゼクロス像が確認できる。また、樹脂泡埋超薄切法や凍結切片法による透過型電子顕微鏡(TEM)で液晶構造を確認することができる。 The presence or absence of the liquid crystal structure in the liquid crystal forming emulsion composition and the cosmetic containing the liquid crystal forming emulsifier of the present invention can be confirmed by observing the liquid crystal composition with a polarizing microscope. The liquid crystal composition can confirm a maltase cross image having a shape unique to a lamellar liquid crystal by observation with a polarizing microscope. In addition, the liquid crystal structure can be confirmed with a transmission electron microscope (TEM) using a resin foam-embedded ultra-thin cutting method or a frozen section method.
本発明の液晶形成用乳化剤を含有する液晶形成乳化組成物および化粧料は、その構造中に多量の結合水を保持していることが特徴であるが、その結合水量は、熱分析(DSC分析)により測定することができる。具体的には、試料中の含水量を変え、おのおの凍結した状態からのDSC分析で得た融解熱総量(吸熱エンタルピーΔH)を縦軸にプロットし、それぞれ水分の実配合量(カールフィッシャー法などで実測する)を横軸にプロットしたときの縦軸と横軸の交点を求め、その値を結合水量とする。 The liquid crystal forming emulsion composition and the cosmetic containing the liquid crystal forming emulsifier of the present invention are characterized in that a large amount of bound water is retained in the structure, and the amount of bound water is determined by thermal analysis (DSC analysis). ). Specifically, the moisture content in the sample was changed, and the total heat of fusion (endothermic enthalpy ΔH) obtained by DSC analysis from each frozen state was plotted on the vertical axis, and the actual water content (Karl Fischer method, etc.) ) Is plotted on the horizontal axis, the intersection of the vertical axis and the horizontal axis is obtained, and the value is defined as the amount of bound water.
本発明の液晶形成乳化組成物および化粧料には、一般に化粧品に使用される界面活性剤、高級アルコール、脂肪酸、活性成分、保湿成分、抗菌成分、粘度調整剤、色素、香料などを併用することができる。 In the liquid crystal forming emulsion composition and cosmetics of the present invention, surfactants generally used in cosmetics, higher alcohols, fatty acids, active ingredients, moisturizing ingredients, antibacterial ingredients, viscosity modifiers, dyes, fragrances, etc. should be used in combination. Can do.
これらを例示すると、界面活性剤としては、POEソルビタンモノオレート、POEソルビタンモノステアレートなどのPOEソルビタン脂肪酸エステル類、POEソルビットモノラウレート、POEソルビットモノオレートなどのPOEソルビット脂肪酸エステル類、POEグリセリンモノステアレート、POEグリセリンモノイソステアレート、POEグリセリントリイソステアレートなどのPOEグリセリン脂肪酸エステル類、POEモノオレート、POEモノイソステアレートなどのPOE脂肪酸エステル類、POEラウリルエーテル、POEオレイルエーテル、POEイソステアリルエーテル、POEステアリルエーテルなどのPOEアルキルエーテル類、POE・POPセチルエーテル、POE・POPデシルテトラデシルエーテルなどのPOE・POPアルキルエーテル類、ショ糖脂肪酸エステル類、ポリグリセリン脂肪酸エステル類などのノニオン界面活性剤、ラウリン酸ナトリウム、パルミチン酸ナトリウムなどの脂肪酸セッケン類、ラウリル硫酸ナトリウム、POEラウリル硫酸ナトリウムなどの硫酸エステル類、ラウロイルサルコシンナトリウム、ココイル−N−メチルタウリンナトリウム、ラウリルグルタミン酸ナトリウムなどのアシル化アミノ酸塩類、モノラウリルリン酸ナトリウムなどのリン酸エステル塩などのアニオン界面活性剤、第4級アンモニウム塩などのカチオン界面活性剤など。 Illustrative of these are surfactants such as POE sorbitan monooleate, POE sorbitan fatty acid esters such as POE sorbitan monostearate, POE sorbite fatty acid esters such as POE sorbite monolaurate and POE sorbite monooleate, and POE glycerin monoester. POE glycerin fatty acid esters such as stearate, POE glycerin monoisostearate, POE glycerin triisostearate, POE fatty acid esters such as POE monooleate and POE monoisostearate, POE lauryl ether, POE oleyl ether, POE isostearyl POE alkyl ethers such as ether and POE stearyl ether, POE / POP cetyl ether, POE / POP decyl tetradecyl ether Non-ionic surfactants such as POE / POP alkyl ethers such as sucrose, sucrose fatty acid esters, polyglycerin fatty acid esters, fatty acid soaps such as sodium laurate and sodium palmitate, sodium lauryl sulfate, sodium POE lauryl sulfate, etc. Sulfates, sodium lauroyl sarcosine sodium, cocoyl-N-methyltaurine sodium, acylated amino acid salts such as sodium lauryl glutamate, anionic surfactants such as monobasyl phosphate sodium phosphate, quaternary ammonium salts Such as cationic surfactants.
高級アルコールとしては、ラウリルアルコール、セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコールなど。 Examples of higher alcohols include lauryl alcohol, cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol.
脂肪酸としては、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、オレイン酸、12−ヒドロキシステアリン酸、イソステアリン酸など。 Examples of fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, 12-hydroxystearic acid, and isostearic acid.
活性成分としては、アスコルビン酸、アスコルビン酸リン酸エステルマグネシウム、パルミチン酸アスコルビル、ステアリン酸アスコルビル、テトライソパルミチン酸アスコルビル、アスコルビン酸グルコシド、アルブチン、エラグ酸、ルシノールなどの美白剤、アミノ酸などのNMF成分、水溶性コラーゲン、エラスチン、グリチルリチン酸、グリチルレチン酸、セラミドなどの肌荒れ防止剤、レチノール、ビタミンA酸などの抗老化剤や各種ビタミン類やその誘導体など。 As active ingredients, ascorbic acid, magnesium ascorbate phosphate ester, ascorbyl palmitate, ascorbyl stearate, ascorbyl tetraisopalmitate, ascorbic acid glucoside, arbutin, ellagic acid, lucinol and other NMF components such as amino acids, Anti-aging agents such as water-soluble collagen, elastin, glycyrrhizic acid, glycyrrhetinic acid and ceramide, anti-aging agents such as retinol and vitamin A acid, various vitamins and their derivatives.
保湿成分としては、ポリエチレングリコール、プロピレングリコール、1,3−ブチレングリコール、ジプロピレングリコール、グリセリン、ソルビトール、キシリトール、マルチトール、コンドロイチン硫酸、ヒアルロン酸、ピロリドンカルボン酸ナトリウムなどを挙げることができる。 Examples of the moisturizing component include polyethylene glycol, propylene glycol, 1,3-butylene glycol, dipropylene glycol, glycerin, sorbitol, xylitol, maltitol, chondroitin sulfate, hyaluronic acid, sodium pyrrolidone carboxylate and the like.
本発明の液晶形成乳化組成物および化粧料を調製する際は、パドルミキサー、ホモミキサーなどの通常の乳化装置が使用できる。調製法は、予め、油性原料と(A)〜(C)成分を、50〜120℃で融解混合しておき、ホモミキサーなどで攪拌下、50〜80℃の温水を投入する方法、または、予め、油性原料と(A)〜(C)成分を、50〜120℃で融解混合しておいたものを、ホモミキサーなどで攪拌下、50〜80℃の温水中に投入する方法などが挙げられる。 When preparing the liquid crystal-forming emulsion composition and cosmetics of the present invention, ordinary emulsification devices such as paddle mixers and homomixers can be used. In the preparation method, the oily raw material and the components (A) to (C) are previously melt-mixed at 50 to 120 ° C. and hot water at 50 to 80 ° C. is added under stirring with a homomixer or the like, or A method in which an oily raw material and components (A) to (C) previously melted and mixed at 50 to 120 ° C. are poured into warm water at 50 to 80 ° C. while stirring with a homomixer or the like. It is done.
本発明の液晶形成乳化組成物および化粧料は、保湿クリーム、エモリエントクリーム、マッサージクリーム、保湿美容液、保湿ローション、エモリエント乳液などのスキンケア化粧料、または、軟膏などの皮膚治療薬などに好適に使用できる。 The liquid crystal forming emulsion composition and cosmetics of the present invention are suitably used for skin care cosmetics such as moisturizing creams, emollient creams, massage creams, moisturizing cosmetics, moisturizing lotions, emollient milks, or skin treatments such as ointments. it can.
以下に実施例を挙げて本発明を更に具体的に説明するが、本発明はこれらによって限定されるものではない。 The present invention will be described more specifically with reference to the following examples, but the present invention is not limited thereto.
(1)液晶形成用乳化剤の調製
下記表1に示す液晶形成用乳化剤を調製した。すなわち、ヒーターおよび温度調節器の付いたステンレス製混合容器中で、表1に記載の成分を70〜75℃で攪拌しながら混合、溶解後、常温まで冷却し液晶形成用乳化剤を得た。
(1) Preparation of liquid crystal forming emulsifier Liquid crystal forming emulsifiers shown in Table 1 below were prepared. That is, in a stainless steel mixing vessel equipped with a heater and a temperature controller, the components listed in Table 1 were mixed and dissolved while stirring at 70 to 75 ° C., and then cooled to room temperature to obtain an emulsifier for liquid crystal formation.
(2)液晶形成乳化組成物の調製
下記表1に示す液晶形成用乳化剤を用いて、下記表2に示す液晶形成乳化組成物を調製した。すなわち、減圧装置とヒーターおよび温度調節器の付いた10リッターかき取り攪拌付きステンレス製ホモミキサー中で、水以外の成分を85〜90℃で混合、溶解し、減圧下(30mmHg以下)、攪拌しながら(攪拌速度5000rpm)、これに同温度の水を徐々に添加した。さらに、同条件で30分間攪拌し、室温まで冷却し液晶形成乳化組成物を得た。液晶形成乳化組成物の調製スケールは、5Kgとした。
(2) Preparation of Liquid Crystal Forming Emulsion Composition Using the liquid crystal forming emulsifier shown in Table 1 below, the liquid crystal forming emulsion composition shown in Table 2 below was prepared. That is, in a stainless steel homomixer with 10 liter scraping and stirring equipped with a decompression device, a heater and a temperature controller, components other than water are mixed and dissolved at 85 to 90 ° C., and stirred under reduced pressure (30 mmHg or less). While stirring (stirring speed: 5000 rpm), water at the same temperature was gradually added thereto. Furthermore, it stirred for 30 minutes on the same conditions, and cooled to room temperature, and obtained the liquid crystal forming emulsion composition. The preparation scale of the liquid crystal forming emulsion composition was 5 kg.
(3)液晶構造の確認
液晶形成乳化組成物をスライドガラス上に薄く延ばした試料を、ホットステージ付き偏光顕微鏡を用いて、25℃と皮膚温度付近の32℃で観察を行った(倍率200倍)。試料のマルターゼクロス像を観察し、マルターゼクロス像を確認できるものを○、できないものを×とした。
(3) Confirmation of liquid crystal structure A sample obtained by thinly extending the liquid crystal forming emulsion composition on a slide glass was observed at 25 ° C. and 32 ° C. near the skin temperature using a polarizing microscope with a hot stage (magnification 200 times). ). The maltase cross image of the sample was observed.
(4)皮膚上での液晶構造の確認
液晶形成乳化組成物を、40歳男性の前腕部内側に塗布して(20μg/cm2)、室温で6時間放置した後、スライドガラス上に転写し試料とした。それを(3)の方法により偏光顕微鏡観察を行い(25℃)、液晶構造の有無を確認した。
その結果、表2に示すように、本発明の液晶形成乳化組成物は、32℃の皮膚温度付近で光学異方性をもつ液晶構造を有していた。かつ、本発明の液晶形成乳化組成物は、皮膚に塗布して6時間後も液晶構造を安定に保っていた。 As a result, as shown in Table 2, the liquid crystal-forming emulsion composition of the present invention had a liquid crystal structure having optical anisotropy near the skin temperature of 32 ° C. Moreover, the liquid crystal forming emulsion composition of the present invention kept the liquid crystal structure stable even after 6 hours from application to the skin.
表3に示す液晶形成乳化組成物を調製し、結合水量を測定した。液晶形成乳化組成物の調製は、実施例1の(2)液晶形成乳化組成物の調製の方法に準じた。結合水量の測定は、表3に示すように、組成中の水分量を変えた試料(水分量20、30、40、50および60%)の融解時の吸熱エンタルピーを示差熱分析計(DSC)により測定し、その値と試料中に含有する水の全量(カールフィシャー法で測定)との回帰直線から求めたy−切片の値から推算した。 Liquid crystal forming emulsion compositions shown in Table 3 were prepared and the amount of bound water was measured. The preparation of the liquid crystal forming emulsion composition was in accordance with the method for preparing the liquid crystal forming emulsion composition in Example 1 (2). As shown in Table 3, the amount of bound water was measured by measuring the endothermic enthalpy at the time of melting of samples (moisture amounts 20, 30, 40, 50 and 60%) in which the amount of moisture in the composition was changed, using a differential thermal analyzer (DSC). And was estimated from the value of the y-intercept obtained from the regression line between the value and the total amount of water contained in the sample (measured by the Karl Fischer method).
その結果、表3に示すように、本発明の液晶形成乳化組成物は、比較例の約2倍量の結合水を含有していた。
表2に示す本発明品12の液晶形成乳化組成物と比較品(乳化組成物)8を用いて、保湿試験を行った。方法は、22℃ 相対湿度45%に調整した恒温・恒湿室で15分間待機したボランティア男女6名(25−45歳)の前腕部内側に、本発明品と比較品をそれぞれ2.5mg/cm2塗布した。塗布後、同条件で15、30、45、60分経過後の塗布部位の皮膚コンダクタンスを、SKICON 200により測定することで保湿効果を評価した。 Using the liquid crystal forming emulsion composition of the present invention product 12 and the comparative product (emulsion composition) 8 shown in Table 2, a moisture retention test was conducted. The method consists of 2.5 mg / day of the product of the present invention and the comparative product on the inner side of the forearm of 6 volunteer men and women (25-45 years old) who waited for 15 minutes in a constant temperature / humidity chamber adjusted to 22% relative humidity 45%. cm 2 was applied. After application, the moisturizing effect was evaluated by measuring skin conductance of the application site after 15, 30, 45 and 60 minutes under the same conditions by SKICON 200.
その結果、図1に示すように、試料塗布1時間後の皮膚コンダクタンスは、本発明品12で100.0μS±9.6であり、一方、比較例8では61.2μS±8.2であった。本発明品は、比較品に対して有意に皮膚コンダクタンスを上昇させることがわかった。したがって、本発明品の保湿効果が確認された。
As a result, as shown in FIG. 1, the skin conductance 1 hour after the sample application was 100.0 μS ± 9.6 for the product of the present invention 12 and 61.2 μS ± 8.2 for Comparative Example 8. It was. The product of the present invention was found to significantly increase the skin conductance relative to the comparative product. Therefore, the moisturizing effect of the product of the present invention was confirmed.
表2に示す本発明品12の液晶形成乳化組成物と比較品(乳化組成物)8を用いて、角質水分蒸散量(TEWL)の測定試験を行った。男性ボランティア(28―55歳)12名を用いて、本発明品12および比較品8の長期連用(21日間)によるTEWL低下効果を評価した。試料の塗布部位は大腿部内側とし、塗布回数は2回/日とした。塗布開始前および塗布開始1、2、3週間経過後の塗布部位のTEWLをキュートメーターにより測定した。なお、測定は、22℃、相対湿度45%に調整した恒温・恒湿室で行った。 Using the liquid crystal forming emulsion composition of the present invention product 12 shown in Table 2 and the comparative product (emulsion composition) 8, a keratin moisture transpiration (TEWL) measurement test was conducted. Twelve male volunteers (28-55 years old) were used to evaluate the effect of TEWL reduction by long-term continuous use (21 days) of the inventive product 12 and the comparative product 8. The application site of the sample was the inside of the thigh, and the application frequency was 2 times / day. The TEWL at the application site before application start and after 1, 2, and 3 weeks after application start was measured with a cut meter. The measurement was performed in a constant temperature / humidity chamber adjusted to 22 ° C. and a relative humidity of 45%.
その結果、図2に示すように、2週間および3週間の連用において、本発明品12を塗布した部位のTEWLが、比較品に対し有意に減少している結果が得られ、本発明品の皮膚改善効果が確認された。
As a result, as shown in FIG. 2, in the continuous use for 2 weeks and 3 weeks, the TEWL of the site where the product 12 of the present invention was applied was significantly decreased compared to the comparative product. A skin improvement effect was confirmed.
モイストクリーム
A 大豆ステロール 1.0質量%
POE(20)大豆ステロール 2.0
水素添加大豆レシチン 1.0
トリ(カプリル酸/カプリン酸)グリセリル 5.0
スクワラン 4.0
トリエチルヘキサノイン 3.0
セチルアルコール 6.0
シクロペンタシロキサン 4.0
ジメチコン(6mm2/s) 2.0
B カーボポール980(2%水溶液) 10.0
1,3−ブチレングリコール 5.0
グリセリン 3.0
L−ヒドロキシプロリン 0.1
EDTA−2Na 0.05
防腐剤 適量
精製水 残部
C アルギニン 0.2
精製水 3.0
D ヒアルロン酸ナトリウム(1%水溶液) 2.0
精製水 2.0
(調製方法)
A、Bをそれぞれ80℃まで加温し、均一にする。80℃でBをホモミキサーで撹拌しながらAを徐々に添加して乳化する。その後、パドルで撹拌しながら冷却し、50℃でC、Dを添加し、35℃で調製を終了する。
Moist cream A soy sterol 1.0% by mass
POE (20) Soybean Sterol 2.0
Hydrogenated soybean lecithin 1.0
Tri (caprylic / capric) glyceryl 5.0
Squalane 4.0
Triethylhexanoin 3.0
Cetyl alcohol 6.0
Cyclopentasiloxane 4.0
Dimethicone (6mm 2 / s) 2.0
B Carbopol 980 (2% aqueous solution) 10.0
1,3-butylene glycol 5.0
Glycerin 3.0
L-hydroxyproline 0.1
EDTA-2Na 0.05
Preservative appropriate amount Purified water Remainder C Arginine 0.2
Purified water 3.0
D Sodium hyaluronate (1% aqueous solution) 2.0
Purified water 2.0
(Preparation method)
A and B are each heated to 80 ° C. to be uniform. While stirring B with a homomixer at 80 ° C., A is gradually added to emulsify. Then, it cools, stirring with a paddle, C and D are added at 50 degreeC, and preparation is complete | finished at 35 degreeC.
モイストエッセンス
A 大豆ステロール 0.5質量%
POE(20)大豆ステロール 0.7
POE(10)大豆ステロール 0.3
水素添加大豆レシチン 0.5
トリ(カプリル酸/カプリン酸)グリセリル 2.0
スクワラン 1.0
トリエチルヘキサノイン 0.5
エチルヘキサン酸セチル 0.5
セチルアルコール 2.0
シクロペンタシロキサン 1.0
ジメチコン(6mm2/s) 0.5
B カーボポール981(2%水溶液) 10.0
クインスシード 0.1
1,3−ブチレングリコール 3.0
ペンチレングリコール 1.5
グリセリン 1.0
EDTA−2Na 0.05
防腐剤 適量
精製水 残部
C アルギニン 0.2
精製水 3.0
D ヒアルロン酸ナトリウム(1%水溶液) 2.0
精製水 2.0
(調製方法)
A、Bをそれぞれ80℃まで加温し、均一にする。80℃でBをホモミキサーで撹拌しながらAを徐々に添加して乳化する。その後、パドルで撹拌しながら冷却し、50℃でC、Dを添加し、35℃で調製を終了する。
Moist Essence A Soybean Sterol 0.5% by mass
POE (20) soybean sterol 0.7
POE (10) soybean sterol 0.3
Hydrogenated soybean lecithin 0.5
Tri (caprylic / capric) glyceryl 2.0
Squalane 1.0
Triethylhexanoin 0.5
Cetyl ethylhexanoate 0.5
Cetyl alcohol 2.0
Cyclopentasiloxane 1.0
Dimethicone (6mm 2 / s) 0.5
B Carbopol 981 (2% aqueous solution) 10.0
Quince Seed 0.1
1,3-butylene glycol 3.0
Pentylene glycol 1.5
Glycerin 1.0
EDTA-2Na 0.05
Preservative appropriate amount Purified water Remainder C Arginine 0.2
Purified water 3.0
D Sodium hyaluronate (1% aqueous solution) 2.0
Purified water 2.0
(Preparation method)
A and B are each heated to 80 ° C. to be uniform. While stirring B with a homomixer at 80 ° C., A is gradually added to emulsify. Then, it cools, stirring with a paddle, C and D are added at 50 degreeC, and preparation is complete | finished at 35 degreeC.
モイスチャー美白クリーム
A 大豆ステロール 1.0質量%
POE(20)大豆ステロール 2.0
水素添加大豆レシチン 0.5
トリ(カプリル酸/カプリン酸)グリセリル 3.0
スクワラン 3.0
テトラヘキシルデカン酸アスコルビル 3.0
トリエチルヘキサノイン 1.0
エチルヘキサン酸セチル 1.0
セチルアルコール 3.0
ベヘニルアルコール 3.5
マイクロクリスタリンワックス 0.3
シクロペンタシロキサン 3.0
ジメチコン(6mm2/s) 1.0
B カーボポール980(2%水溶液) 12.0
キサンタンガム(2%水溶液) 3.0
1,3−ブチレングリコール 5.0
グリセリン 1.0
PEG−30 0.3
EDTA−2Na 0.05
防腐剤 適量
精製水 残部
C アルギニン 0.2
精製水 3.0
D ヒアルロン酸ナトリウム(1%水溶液) 2.0
精製水 2.0
(調製方法)
A、Bをそれぞれ80℃まで加温し、均一にする。80℃でBをホモミキサーで撹拌しながらAを徐々に添加して乳化する。その後、パドルで撹拌しながら冷却し、50℃でC、D添加し、35℃で調製を終了する。
Moisture whitening cream A soy sterol 1.0% by mass
POE (20) Soybean Sterol 2.0
Hydrogenated soybean lecithin 0.5
Tri (caprylic / capric) glyceryl 3.0
Squalane 3.0
Ascorbyl tetrahexyldecanoate 3.0
Triethylhexanoin 1.0
Cetyl ethylhexanoate 1.0
Cetyl alcohol 3.0
Behenyl alcohol 3.5
Microcrystalline wax 0.3
Cyclopentasiloxane 3.0
Dimethicone (6mm 2 / s) 1.0
B Carbopol 980 (2% aqueous solution) 12.0
Xanthan gum (2% aqueous solution) 3.0
1,3-butylene glycol 5.0
Glycerin 1.0
PEG-30 0.3
EDTA-2Na 0.05
Preservative appropriate amount Purified water Remainder C Arginine 0.2
Purified water 3.0
D Sodium hyaluronate (1% aqueous solution) 2.0
Purified water 2.0
(Preparation method)
A and B are each heated to 80 ° C. to be uniform. While stirring B with a homomixer at 80 ° C., A is gradually added to emulsify. Then, it cools with stirring with a paddle, C and D are added at 50 degreeC, and preparation is complete | finished at 35 degreeC.
アンチエイジングクリーム(ライトタイプ)
A 本発明品2の液晶形成用乳化剤 5.0質量%
セテアリルアルコール 2.5
マイクロクリスタリンワックス 0.3
トリ(カプリル酸/カプリン酸)グリセリル 5.0
メドウフォーム油 3.0
スクワラン 3.0
トリエチルヘキサノイン 2.0
マカデミアナッツ油 1.0
水添レチノールとトリ(カプリル酸/カプリン酸)
グリセリル)の混合物 1.0
シクロペンタシロキサン 3.0
ジメチコン(6mm2/s) 2.0
B カーボポール980(2%水溶液) 12.0
キサンタンガム(2%水溶液) 3.0
グリセリン 4.0
1,3−ブチレングリコール 3.0
ペンチレングリコール 2.0
EDTA−2Na 0.05
防腐剤 適量
精製水 残部
C アルギニン 0.2
精製水 3.0
D ヒアルロン酸ナトリウム(1%水溶液) 2.0
精製水 2.0
(調製方法)
A、Bをそれぞれ80℃まで加温し、均一にする。80℃でBをホモミキサーで撹拌しながらAを徐々に添加して乳化する。その後、パドルで撹拌しながら冷却し、50℃でC、Dを添加し、35℃で調製を終了する。
Anti-aging cream (light type)
A 5.0% by mass of the emulsifier for liquid crystal formation of the present invention product
Cetearyl alcohol 2.5
Microcrystalline wax 0.3
Tri (caprylic / capric) glyceryl 5.0
Meadow Foam Oil 3.0
Squalane 3.0
Triethylhexanoin 2.0
Macadamia nut oil 1.0
Hydrogenated retinol and tri (caprylic acid / capric acid)
Glyceryl) mixture 1.0
Cyclopentasiloxane 3.0
Dimethicone (6mm 2 / s) 2.0
B Carbopol 980 (2% aqueous solution) 12.0
Xanthan gum (2% aqueous solution) 3.0
Glycerin 4.0
1,3-butylene glycol 3.0
Pentylene glycol 2.0
EDTA-2Na 0.05
Preservative appropriate amount Purified water Remainder C Arginine 0.2
Purified water 3.0
D Sodium hyaluronate (1% aqueous solution) 2.0
Purified water 2.0
(Preparation method)
A and B are each heated to 80 ° C. to be uniform. While stirring B with a homomixer at 80 ° C., A is gradually added to emulsify. Then, it cools, stirring with a paddle, C and D are added at 50 degreeC, and preparation is complete | finished at 35 degreeC.
実施例5〜8の化粧料は実施例1の液晶の確認方法を用いて測定したところ液晶を形成していることが確認され、また実施例4の試験を行うことによってスキンケア効果を有することを確認した。 The cosmetics of Examples 5 to 8 were confirmed to form a liquid crystal when measured using the liquid crystal confirmation method of Example 1, and to have a skin care effect by performing the test of Example 4. confirmed.
本発明のステロール、ポリオキシエチレンステロール類およびレシチンを必須成分とする液晶形成用乳化剤を利用することで、角質細胞間脂質と類似の液晶構造を形成し、組成物を皮膚に塗布した時の水分の蒸散を液晶が抑えることにより優れたスキンケア効果や皮膚改善効果を示す液晶形成乳化組成物および化粧料を得ることができた。 By using an emulsifier for liquid crystal formation comprising sterols, polyoxyethylene sterols and lecithin as essential components of the present invention, a liquid crystal structure similar to keratinocyte lipids is formed, and moisture when the composition is applied to the skin By suppressing the transpiration of the liquid crystal, it was possible to obtain a liquid crystal forming emulsion composition and a cosmetic that exhibit excellent skin care effect and skin improvement effect.
Claims (5)
(A)ステロール
(B)ポリオキシエチレンステロール
(C)レシチン An emulsifier for forming a liquid crystal containing the following (A) to (C) as essential components.
(A) Sterol (B) Polyoxyethylene sterol (C) Lecithin
(A)/(B)=10/90〜90/10
かつ
[(A)+(B)]/(C)=98/2〜70/30
である請求項1に記載の液晶形成用乳化剤。 The ratio (mass ratio) of the components (A) to (C) is
(A) / (B) = 10/90 to 90/10
And [(A) + (B)] / (C) = 98/2 to 70/30
The emulsifier for liquid crystal formation according to claim 1.
(A)/(B)=10/90〜90/10
かつ
[(A)+(B)]/(C)=98/2〜70/30
である請求項3に記載の液晶形成乳化組成物。 The ratio (mass ratio) of the components (A) to (C) is
(A) / (B) = 10/90 to 90/10
And [(A) + (B)] / (C) = 98/2 to 70/30
The liquid crystal forming emulsion composition according to claim 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007237481A JP2008115162A (en) | 2006-10-13 | 2007-09-13 | Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006279526 | 2006-10-13 | ||
| JP2007237481A JP2008115162A (en) | 2006-10-13 | 2007-09-13 | Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008115162A true JP2008115162A (en) | 2008-05-22 |
Family
ID=39501405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007237481A Pending JP2008115162A (en) | 2006-10-13 | 2007-09-13 | Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008115162A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010280587A (en) * | 2009-06-03 | 2010-12-16 | Nikko Chemical Co Ltd | Emulsifier for forming liquid crystal and liquid-crystal-forming emulsified composition and cosmetic containing the same |
| CN103202772A (en) * | 2013-01-17 | 2013-07-17 | 广州环亚化妆品科技有限公司 | Cream composition with stable liquid crystal structure and preparation method thereof |
| JP2014040400A (en) * | 2012-08-23 | 2014-03-06 | Kao Corp | Aqueous composition in container |
| JP2014237595A (en) * | 2013-06-06 | 2014-12-18 | ポーラ化成工業株式会社 | Emulsified composition |
| WO2017090740A1 (en) * | 2015-11-26 | 2017-06-01 | 株式会社コーセー | Bicell structure-containing composition |
| CN108743453A (en) * | 2018-09-10 | 2018-11-06 | 无限极(中国)有限公司 | A kind of compounding layered liquid crystal emulsifier and its application and the cosmetics with layered liquid crystal structure |
| CN115708783A (en) * | 2021-08-23 | 2023-02-24 | 美特瑞生物科技(上海)有限公司 | Formula of liquid crystal emulsifier composition and application of liquid crystal emulsifier composition in cosmetics |
| CN117122523A (en) * | 2023-08-21 | 2023-11-28 | 广州泰诺生物科技有限公司 | Bionic liquid crystal composition and preparation method and application thereof |
-
2007
- 2007-09-13 JP JP2007237481A patent/JP2008115162A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010280587A (en) * | 2009-06-03 | 2010-12-16 | Nikko Chemical Co Ltd | Emulsifier for forming liquid crystal and liquid-crystal-forming emulsified composition and cosmetic containing the same |
| JP2014040400A (en) * | 2012-08-23 | 2014-03-06 | Kao Corp | Aqueous composition in container |
| CN103202772A (en) * | 2013-01-17 | 2013-07-17 | 广州环亚化妆品科技有限公司 | Cream composition with stable liquid crystal structure and preparation method thereof |
| JP2014237595A (en) * | 2013-06-06 | 2014-12-18 | ポーラ化成工業株式会社 | Emulsified composition |
| WO2017090740A1 (en) * | 2015-11-26 | 2017-06-01 | 株式会社コーセー | Bicell structure-containing composition |
| JPWO2017090740A1 (en) * | 2015-11-26 | 2018-05-31 | 株式会社コーセー | Composition containing bicell structure |
| CN108743453A (en) * | 2018-09-10 | 2018-11-06 | 无限极(中国)有限公司 | A kind of compounding layered liquid crystal emulsifier and its application and the cosmetics with layered liquid crystal structure |
| CN115708783A (en) * | 2021-08-23 | 2023-02-24 | 美特瑞生物科技(上海)有限公司 | Formula of liquid crystal emulsifier composition and application of liquid crystal emulsifier composition in cosmetics |
| CN117122523A (en) * | 2023-08-21 | 2023-11-28 | 广州泰诺生物科技有限公司 | Bionic liquid crystal composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010280587A (en) | Emulsifier for forming liquid crystal and liquid-crystal-forming emulsified composition and cosmetic containing the same | |
| CN101772339B (en) | Oil-in-water emulsion composition and method for producing the same | |
| CN107613952B (en) | Oil-in-water emulsion composition and method for producing same | |
| KR101052493B1 (en) | Blessicle dispersions and cosmetics containing the same | |
| CA2564506C (en) | Multi-lamellar liquid crystal emulsion system | |
| JP2008115162A (en) | Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition | |
| JP6377381B2 (en) | Liposome composition | |
| KR101577874B1 (en) | Liquid crystal cosmetic composition having similar skin lipid composition and containing glucosylceramide, and preparation method thereof | |
| JP2011144133A (en) | Emulsified composition | |
| JP2010059066A (en) | Alkyl glyceryl ether-mixed composition and cosmetic or skin care preparation containing the same | |
| JP6054886B2 (en) | Improved moisturizer blend | |
| JP5774986B2 (en) | Vesicle composition and cosmetics containing the same | |
| WO2012017733A1 (en) | Skin cosmetic | |
| KR20160082054A (en) | Emulsifier-Free Cosmetic Composition of the Oil-in-Water Emulsion Type and Preparation Method Thereof | |
| JP2007254404A (en) | Oil in water emulsion whitely turbid skin cosmetic | |
| JP4891695B2 (en) | Ceramide-containing topical skin preparation | |
| JP2000072618A (en) | Emulsifying agent for preparation for external use for skin | |
| JP4817435B2 (en) | Topical skin preparation | |
| JP5468960B2 (en) | Emulsified cosmetics | |
| JP6869500B2 (en) | External preparations and methods for manufacturing external preparations | |
| KR20230150260A (en) | liposome composition | |
| JP2013049635A (en) | Liquid crystal structure for moisturizing skin, and skin care composition | |
| JP2020164439A (en) | Stabilized high internal phase W / O type emulsified composition and cosmetics using it | |
| JP2023046917A (en) | Cosmetic composition containing ceramide-containing lipid particles | |
| HK40094248A (en) | Liposome composition |